Published with this product (23)
2025Molecular Pain
Hengwei Sheng, Hualei Gong, Xiaolin Liu, Wenbo Wu, Helena Soares da Silva, Sen Huang, and Kai Mo
doi:10.1177/174480692513894162025Bone Research, 13, 34
Characterizing a New Rat Model of Chronic Pain After Spine Surgery
Qichao Wu, Neil C. Ford, Shaoqiu He, Chi Zhang, Xiang Cui, Jing Liu, Xueming Chen, Xu Cao, Yun Guan, and Lei Zang
doi:10.1038/s41413-025-00408-12022
Kelsey Vollmer, Lisa Green, Roger Grant, Kion Winston, Elizabeth Doncheck, Christopher Bowen, Jacqueline Paniccia, Rachel Clarke, Annika Tiller, Preston Siegler, Benjamin Siemsen, Adam Denton, Thomas Jhou, Jennifer Rinker, Michael Scoeld, and James Otis
doi:10.21203/rs.3.rs-1527325/v12021Pain Reports
Amanda Lillywhite, Stephen G. Woodhams, Sara V. Goncalves, David J.G. Watson, Li Li, James J. Burston, Peter R.W. Gowler,, Meritxell Canals, David A. Walsh, Gareth J. Hathway, Victoria Chapman
doi:10.1097/PR9.00000000000009562021International Journal of Molecular Sciences, 22(4), 189
Ching Chang, Hung-Kai Liu, Chao-Bin Yeh, Ming-Lin Yang, Wen-Chieh Liao Chiung-Hui Liu, and To-Jung Tseng
doi:10.3390/ijms22041891
Description
Three types of opioid receptors have been cloned -- mu, delta, and kappa. Opioid receptors are seven transmembrane G-protein coupled receptors. They share a high degree of homology and are most divergent at the N- and C-termini. Activation of mu opioid receptors leads to a decrease in neuronal excitability.
Product Highlights:
You'll also need
What this product needs to grow and work as described.
- Mu Opioid Receptor Blocking PeptideP10104 · 50 ul Blocking Peptide @ 2mgs/ml$95.00
Related products
For research use only. Not for diagnostic or clinical use.